ArticleJournal of neuro-oncology2026

MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy.

Terry J Prins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.